Clinical Trial Update: Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used [Phase 4]

View source ↗

Summary

Phase 4 trial update detailing biological and clinical measurements after systemic leakage occurs when citrate or heparin lock solutions are used in catheter ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Citrate lock solution (trisodium citrate)
• Heparin lock solution (unfractionated heparin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Acute Renal Insufficiency | Phase 4 | Status: COMPLETED